Deutsches Konsortium für Translationale Krebsforschung

391.5k citations
9.8k papers ·

Impact in

  • Genetics top 0.5%
    • Glioma Diagnosis and Treatment
  • Oncology top 1%
    • Cancer Immunotherapy and Biomarkers
    • Cancer Cells and Metastasis
    • CAR-T cell therapy research

Papers in

    • Glioma Diagnosis and Treatment 1.1k
    • Cancer Immunotherapy and Biomarkers 513
    • CAR-T cell therapy research 265

Deutsches Konsortium für Translationale Krebsforschung

9.3k papers receiving 391.1k citations

Peers

Deutsches Konsortium für Translationale Krebsforschung
Comparison fields: 5 of 228
  • Genetics 59.7k
  • Oncology 85k
  • Cancer Research 33.9k
  • Hematology 16.9k
  • Pulmonary and Respiratory Medicine 37.5k
Replace National Center for Tumor Diseases with:
National Center for Tumor Diseases Germany
University Medical Centre Mannheim Germany
Erasmus MC Cancer Institute Netherlands
Fondazione IRCCS Istituto Nazionale dei Tumori Italy
Roche (Switzerland) Switzerland
Novartis (Switzerland) Switzerland
IRCCS Humanitas Research Hospital Italy
European Institute of Oncology Italy
European Organisation for Research and Treatment of Cancer Belgium
Centre Léon Bérard France
Deutsches Konsortium für Translationale Krebsforschung relative to National Center for Tumor Diseases Germany National Center for Tumor Diseases's profile →
Citations per field
00.5×1.5×2.1×
National Center for Tumor Diseases · 1×
Citations per year

Countries citing scholars working at Deutsches Konsortium für Translationale Krebsforschung

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at Deutsches Konsortium für Translationale Krebsforschung. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Deutsches Konsortium für Translationale Krebsforschung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deutsches Konsortium für Translationale Krebsforschung more than expected).

Fields of papers published by authors at Deutsches Konsortium für Translationale Krebsforschung

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with Deutsches Konsortium für Translationale Krebsforschung at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Deutsches Konsortium für Translationale Krebsforschung at the time of their publication.

About Deutsches Konsortium für Translationale Krebsforschung

In recent decades, authors affiliated with Deutsches Konsortium für Translationale Krebsforschung have published 9.8k papers, which have received a total of 391.5k indexed citations . Scholars at this organization have produced 1.2k papers in Genetics, 2.2k papers in Oncology, 780 papers in Cancer Research, 602 papers in Hematology and 363 papers in Radiation on the topics of Glioma Diagnosis and Treatment (1.1k papers), Cancer Immunotherapy and Biomarkers (513 papers), Acute Myeloid Leukemia Research (373 papers), Advanced Radiotherapy Techniques (356 papers), Cancer Genomics and Diagnostics (299 papers), Radiation Therapy and Dosimetry (285 papers), CAR-T cell therapy research (265 papers) and Medical Imaging Techniques and Applications (252 papers). Their work is cited by papers focused on Genetics (59.7k citations), Oncology (85k citations), Cancer Research (33.9k citations), Hematology (16.9k citations) and Pulmonary and Respiratory Medicine (37.5k citations). Authors at Deutsches Konsortium für Translationale Krebsforschung collaborate with scholars in Germany, United States and Switzerland and have published in prestigious journals including Cancers, Nature Communications, Neuro-Oncology, International Journal of Cancer and Oncotarget. Some of Deutsches Konsortium für Translationale Krebsforschung's most productive authors include Hermann Brenner, Guido Reifenberger, Andreas von Deimling, Florian R. Greten, David N. Louis, Arie Perry, Dominique F. Figarella-Branger, David W. Ellison, Simone Fulda and Sergei I. Grivennikov.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore institutions with similar magnitude of impact